Gedeon Richter is a specialized pharmaceutical company focused on innovation, headquartered in Hungary. It provides effective treatments in over 100 countries worldwide. The company’s product portfolio covers numerous therapeutic areas, including women’s health, the central nervous system, and cardiovascular diseases. Gedeon Richter manufactures more than 200 medicinal products, including original, generic, and licensed medicines, offering effective and affordable treatment in key therapeutic fields.

Gedeon Richter has a diverse cardiology portfolio, delivering patients high-quality and modern treatment aligned with the latest European and global guidelines. The company is among the industry leaders.

1. BEWIM is one of the company’s key products on the Bulgarian pharmaceutical market. It contains the active substance prasugrel, intended for the treatment of patients with acute coronary syndrome, and is the most prescribed potent antiplatelet agent in Bulgaria.
2. Telexer is the first generic product from the DOAC (Direct Oral Anticoagulants) group in Bulgaria. It contains dabigatran in 110 mg and 150 mg doses and has been available in Bulgaria since the end of 2023.
3. Dironorm is an original fixed-dose combination created by Gedeon Richter, containing lisinopril and amlodipine. It is the most preferred dual fixed combination for the treatment of arterial hypertension in Bulgaria.
4. Zaranta is one of the main products in Gedeon Richter’s cardiology portfolio. It contains rosuvastatin in 5, 10, and 20 mg forms. Zaranta is the first generic rosuvastatin with its own efficacy and safety study.